{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T23:06:58Z","timestamp":1754262418051,"version":"3.41.0"},"reference-count":50,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Given the known side effects of opioids and their potential effects on cognition, we sought to evaluate the benefits of motivational interviewing (MI) to promote physical activity on 2 subsets of participants with fibromyalgia (FM): nonusers and users of opioids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>This was a secondary data analysis of a 36-week randomized controlled trial to assess the efficacy of MI to promote physical activity among participants with FM. Participants were randomized to 1 of 2 treatment arms: 6 phone-based MI sessions (n = 107) or 6 sessions of FM self-management instructions [attention control (AC), n = 109]. The primary outcomes were changes in physical function (Medical Outcomes Study Short Form-36), pain severity (Brief Pain Inventory), global FM symptom severity (Fibromyalgia Impact Questionnaire), and the amount of light to moderate physical activity (LMPA) from baseline to each followup visit. At study entry, subjects were categorized as opioid nonusers versus users. Repeated measures ANOVA was used to assess treatment effects adjusting for potential confounders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Of the 216 participants, 145 (67%) were nonusers and 71 (33%) were opioid users. Among nonusers, MI was associated with improved physical function, reduced pain severity, and global FM severity, and increased LMPA at 6-month followup. Among opioid users, there were no significant differences in any outcome measures between the MI and AC groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Exercise-based MI was associated with sustained clinical benefits 6 months after completion of therapy, but only for those who were not taking opioids.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.161003","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T02:20:24Z","timestamp":1480645224000},"page":"505-511","source":"Crossref","is-referenced-by-count":10,"title":["Sustained Benefits of Exercise-based Motivational Interviewing, but Only among Nonusers of Opioids in Patients with Fibromyalgia"],"prefix":"10.3899","volume":"44","author":[{"given":"Sunghye","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Slaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis C.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2018112909371157000_44.4.505.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23176"},{"key":"2018112909371157000_44.4.505.2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40273-014-0137-y","article-title":"Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden","volume":"32","author":"Skaer","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"2018112909371157000_44.4.505.3","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X10666140914155304"},{"key":"2018112909371157000_44.4.505.4","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1002\/art.39252","article-title":"Differences in sedentary time and physical activity between female patients with fibromyalgia and healthy controls: the al-\u00c1ndalus project","volume":"67","author":"Segura-Jim\u00e9nez","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2018112909371157000_44.4.505.5","first-page":"333","article-title":"Adherence during an individualized home based 12-week exercise program in women with fibromyalgia","volume":"33","author":"Dobkin","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909371157000_44.4.505.6","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11606-016-3685-3","article-title":"Motivational interviewing improves medication adherence: a systematic review and meta-analysis","volume":"31","author":"Palacio","year":"2016","journal-title":"J Gen Intern Med"},{"key":"2018112909371157000_44.4.505.7","doi-asserted-by":"crossref","unstructured":"Lindson-Hawley N Thompson TP Begh R . Motivational interviewing for smoking cessation. Cochrane Database Syst Rev 2015:CD006936.","DOI":"10.1002\/14651858.CD006936.pub3"},{"key":"2018112909371157000_44.4.505.8","doi-asserted-by":"publisher","DOI":"10.1177\/0269215514536210"},{"key":"2018112909371157000_44.4.505.9","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318254ac76"},{"key":"2018112909371157000_44.4.505.10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anclin.2016.01.002","article-title":"Chronic pain and the opioid conundrum","volume":"34","author":"Webster","year":"2016","journal-title":"Anesthesiol Clin"},{"key":"2018112909371157000_44.4.505.11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000839"},{"key":"2018112909371157000_44.4.505.12","doi-asserted-by":"crossref","unstructured":"Macfarlane GJ Kronisch C Dean LE Atzeni F Hauser W Fluss E EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 2016 Jul 4 (E-pub ahead of print).","DOI":"10.1136\/annrheumdis-2016-209724"},{"key":"2018112909371157000_44.4.505.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.002"},{"key":"2018112909371157000_44.4.505.14","first-page":"898493","article-title":"Opioid use in fibromyalgia is associated with negative health related measures in a prospective cohort study","volume":"2013","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Treat"},{"key":"2018112909371157000_44.4.505.15","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-007-9033-y"},{"key":"2018112909371157000_44.4.505.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330203"},{"key":"2018112909371157000_44.4.505.17","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200409000-00005"},{"issue":"Suppl 39","key":"2018112909371157000_44.4.505.18","first-page":"S154","article-title":"The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses","volume":"23","author":"Bennett","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909371157000_44.4.505.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2010.08.014"},{"key":"2018112909371157000_44.4.505.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0587-0"},{"key":"2018112909371157000_44.4.505.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.11.001"},{"key":"2018112909371157000_44.4.505.22","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-200107000-00010"},{"key":"2018112909371157000_44.4.505.23","first-page":"582","article-title":"High or low intensity aerobic fitness training in fibromyalgia: does it matter?","volume":"29","author":"van Santen","year":"2002","journal-title":"J Rheumatol"},{"key":"2018112909371157000_44.4.505.24","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"2018112909371157000_44.4.505.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(03)00116-5"},{"key":"2018112909371157000_44.4.505.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.20983"},{"key":"2018112909371157000_44.4.505.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.026"},{"key":"2018112909371157000_44.4.505.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2003.12.005"},{"key":"2018112909371157000_44.4.505.29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/papr.12302","article-title":"The comparative burden of chronic widespread pain and fibromyalgia in the United States","volume":"16","author":"Schaefer","year":"2016","journal-title":"Pain Pract"},{"key":"2018112909371157000_44.4.505.30","unstructured":"Miller WR Rollnick S . Motivational interviewing: preparing people to change addictive behavior. New York: Guilford Press; 1991."},{"key":"2018112909371157000_44.4.505.31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1467-789X.2011.00892.x","article-title":"Motivational interviewing to improve weight loss in overweight and\/or obese patients: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Armstrong","year":"2011","journal-title":"Obes Rev"},{"key":"2018112909371157000_44.4.505.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2702.2012.04317.x"},{"key":"2018112909371157000_44.4.505.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2015.03.008"},{"key":"2018112909371157000_44.4.505.34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.5.501"},{"key":"2018112909371157000_44.4.505.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.02.015"},{"key":"2018112909371157000_44.4.505.36","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.neubiorev.2013.08.006","article-title":"The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways","volume":"37","author":"Garland","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"2018112909371157000_44.4.505.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(99)01465-4"},{"key":"2018112909371157000_44.4.505.38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq138"},{"key":"2018112909371157000_44.4.505.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2013.02.005"},{"key":"2018112909371157000_44.4.505.40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3565(25)38666-0","article-title":"Dynorphin A-(1\u201313) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice","volume":"269","author":"Itoh","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"2018112909371157000_44.4.505.41","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(87)90036-6"},{"key":"2018112909371157000_44.4.505.42","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3182863447"},{"key":"2018112909371157000_44.4.505.43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.chest.2016.05.022","article-title":"Opioids and sleep-disordered breathing","volume":"150","author":"Van Ryswyk","year":"2016","journal-title":"Chest"},{"key":"2018112909371157000_44.4.505.44","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-008-0208-4"},{"key":"2018112909371157000_44.4.505.45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5664\/jcsm.26908","article-title":"Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing","volume":"3","author":"Walker","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"Suppl 1","key":"2018112909371157000_44.4.505.46","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1111\/pme.12910","article-title":"Opioid therapy and sleep disorders: risks and mitigation strategies","volume":"16","author":"Cheatle","year":"2015","journal-title":"Pain Med"},{"key":"2018112909371157000_44.4.505.47","doi-asserted-by":"crossref","unstructured":"Krebs EE Kroenke K Wu J Bair MJ Kozak MA Yu Z . Opioid use as a predictor of health care use and pain outcomes: analysis of clinical trial data. Pain Med 2016 Feb 25 (E-pub ahead of print).","DOI":"10.1093\/pm\/pnw002"},{"key":"2018112909371157000_44.4.505.48","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11606-015-3332-4","article-title":"Overdoses in patients on opioids: risks associated with mental health conditions and their treatment","volume":"30","author":"Bair","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2018112909371157000_44.4.505.49","doi-asserted-by":"crossref","unstructured":"Halpern R Shah SN Cappelleri JC Masters ET Clair A . Evaluating guideline-recommended pain medication use among patients with newly diagnosed fibromyalgia. Pain Pract 2015 Oct 7 (E-pub ahead of print).","DOI":"10.1111\/papr.12364"},{"issue":"Suppl 79","key":"2018112909371157000_44.4.505.50","first-page":"S94","article-title":"Comparison of the International Physical Activity Questionnaire (IPAQ) with a multi-sensor armband accelerometer in women with fibromyalgia: the al-\u00c1ndalus project","volume":"31","author":"Segura-Jim\u00e9nez","year":"2013","journal-title":"Clin Exp Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.161003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:38:23Z","timestamp":1749775103000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.161003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,1]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3899\/jrheum.161003"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.161003","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"type":"print","value":"0315-162X"},{"type":"electronic","value":"1499-2752"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}